(Q38758444)

English

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

scientific article published on May 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study (English)

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

0 references

Helmut Butzkueven

2

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

3

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

10

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

1

object named as

Ludwig Kappos

1 reference

Europe PubMed Central

18 July 2018

author name string

Timothy Spelman

4

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Fabio Pellegrini

5

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Yi Chen

6

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Qunming Dong

7

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Harold Koendgen

8

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Shibeshih Belachew

9

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Tysabri® Observational Program (TOP) Investigators

11

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

publication date

30 May 2017

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

24

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

963-973

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

7

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Defining secondary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

27 July 2018

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

27 July 2018

Age and disability accumulation in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

27 July 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

27 July 2018

https://api.crossref.org/works/10.1177%2F1352458517709619

21 January 2018

Diagnostic tests. 1: Sensitivity and specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

27 July 2018

Defining reliable disability outcomes in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Defining the clinical course of multiple sclerosis: the 2013 revisions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Composite end points to assess delay of disability progression by MS treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Progression in multiple sclerosis: further evidence of an age dependent process.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Age at disability milestones in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6029149

31 August 2018

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458517709619

21 January 2018

Natural history of secondary-progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458517709619

21 January 2018

Detecting clinically-relevant changes in progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28554238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/28554238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28554238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1352458517709619

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

1 reference

Europe PubMed Central

18 July 2018

http://europepmc.org/abstract/PMC/6029149

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38758444&oldid=1900265803"